Exane Derivatives’s Zoom ZM Stock Holding History

Exane Derivatives’s Portfolio ZM Stock Details ZM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-82	Closed	-$9.61K	–	1037
2022 Q1	$9.61K	Buy	+82	New	+$11.2K	﹤0.01%	679
2021 Q4	–	Sell	-317	Closed	-$82.9K	–	1088
2021 Q3	$82.9K	Buy	317 +177	+126%	+$59.7K	0.02%	552
2021 Q2	$53K	Sell	140 -70	-33%	-$23.3K	0.01%	645
2021 Q1	$67.5K	Sell	210 -404	-66%	-$149K	0.02%	483
2020 Q4	$207K	Buy	+614	New	+$274K	0.06%	305

Other funds holding ZM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Exane Derivatives's ZM Position: Q2 2022 in Review

Exane Derivatives sold out of Zoom (ZM) in Q2 2022, closing a stake of 82 shares — an estimated $9.61K sold.

Exane Derivatives first reported a position in ZM in Q4 2020 and held it in 5 quarters. The position peaked at $207K in Q4 2020. 754 funds tracked by Wall St. Rank hold ZM as of Q2 2022.

Exane Derivatives reported no remaining Zoom position as of Q2 2022 after selling out during the quarter.
Exane Derivatives sold 82 Zoom shares in Q2 2022, an estimated $9.61K.
Exane Derivatives first reported a position in Zoom in Q4 2020 and held it in 5 quarters.
Exane Derivatives's Zoom position peaked at $207K in Q4 2020.
754 funds tracked by Wall St. Rank held Zoom as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.